Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

Financial Release: JOY GROUP Achieves 36% Revenue Growth to Reach US$483M in 2024 with Growth from Multi Beauty Categories

SHANGHAI, April 9, 2025 /PRNewswire/ -- JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced its financial results for the 2024 fiscal year, achieving...

SUPCON’s AI-Powered Full-stack Industrial Automation Solutions Shine at Hannover Messe 2025

HANNOVER, Germany, April 9, 2025 /PRNewswire/ -- From March 31 to April 4, — the world's leading trade fair for industrial technology — was...

DREO Summer Lineup Redefines Home Cooling, Launching 12 Smart Innovations for 2025

CLIFTON, N.J., April 9, 2025 /PRNewswire/ -- On April 8, DREO - a pioneering smart home brand - unveiled its biggest summer launch to date at...